UNIVERSAL HEALTH SERVICES-B (UHS) Fundamental Analysis & Valuation

NYSE:UHS • US9139031002

192.65 USD
-4.31 (-2.19%)
At close: Mar 6, 2026
192.65 USD
0 (0%)
After Hours: 3/6/2026, 7:52:17 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This UHS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Overall UHS gets a fundamental rating of 6 out of 10. We evaluated UHS against 101 industry peers in the Health Care Providers & Services industry. UHS scores excellent on profitability, but there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on UHS. With these ratings, UHS could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

7

1. UHS Profitability Analysis

1.1 Basic Checks

  • UHS had positive earnings in the past year.
  • UHS had a positive operating cash flow in the past year.
  • UHS had positive earnings in each of the past 5 years.
  • In the past 5 years UHS always reported a positive cash flow from operatings.
UHS Yearly Net Income VS EBIT VS OCF VS FCFUHS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • With an excellent Return On Assets value of 9.59%, UHS belongs to the best of the industry, outperforming 93.07% of the companies in the same industry.
  • UHS's Return On Equity of 20.46% is amongst the best of the industry. UHS outperforms 88.12% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 12.52%, UHS belongs to the top of the industry, outperforming 87.13% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for UHS is in line with the industry average of 9.07%.
  • The 3 year average ROIC (10.23%) for UHS is below the current ROIC(12.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.59%
ROE 20.46%
ROIC 12.52%
ROA(3y)7.54%
ROA(5y)7.04%
ROE(3y)16.42%
ROE(5y)15.38%
ROIC(3y)10.23%
ROIC(5y)9.37%
UHS Yearly ROA, ROE, ROICUHS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • UHS has a better Profit Margin (8.57%) than 90.10% of its industry peers.
  • UHS's Profit Margin has been stable in the last couple of years.
  • With an excellent Operating Margin value of 11.48%, UHS belongs to the best of the industry, outperforming 81.19% of the companies in the same industry.
  • In the last couple of years the Operating Margin of UHS has remained more or less at the same level.
Industry RankSector Rank
OM 11.48%
PM (TTM) 8.57%
GM N/A
OM growth 3Y15.31%
OM growth 5Y-0.46%
PM growth 3Y19.4%
PM growth 5Y1.04%
GM growth 3YN/A
GM growth 5YN/A
UHS Yearly Profit, Operating, Gross MarginsUHS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. UHS Health Analysis

2.1 Basic Checks

  • UHS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, UHS has less shares outstanding
  • Compared to 5 years ago, UHS has less shares outstanding
  • Compared to 1 year ago, UHS has an improved debt to assets ratio.
UHS Yearly Shares OutstandingUHS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
UHS Yearly Total Debt VS Total AssetsUHS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • UHS has an Altman-Z score of 3.08. This indicates that UHS is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.08, UHS is in the better half of the industry, outperforming 68.32% of the companies in the same industry.
  • The Debt to FCF ratio of UHS is 5.60, which is a neutral value as it means it would take UHS, 5.60 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 5.60, UHS is doing good in the industry, outperforming 60.40% of the companies in the same industry.
  • UHS has a Debt/Equity ratio of 0.55. This is a neutral value indicating UHS is somewhat dependend on debt financing.
  • UHS has a better Debt to Equity ratio (0.55) than 61.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 5.6
Altman-Z 3.08
ROIC/WACC1.64
WACC7.61%
UHS Yearly LT Debt VS Equity VS FCFUHS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 1.05 indicates that UHS should not have too much problems paying its short term obligations.
  • UHS has a worse Current ratio (1.05) than 64.36% of its industry peers.
  • A Quick Ratio of 0.98 indicates that UHS may have some problems paying its short term obligations.
  • The Quick ratio of UHS (0.98) is worse than 63.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.98
UHS Yearly Current Assets VS Current LiabilitesUHS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. UHS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 30.77% over the past year.
  • The Earnings Per Share has been growing by 14.35% on average over the past years. This is quite good.
  • Looking at the last year, UHS shows a quite strong growth in Revenue. The Revenue has grown by 9.71% in the last year.
  • The Revenue has been growing by 8.48% on average over the past years. This is quite good.
EPS 1Y (TTM)30.77%
EPS 3Y29.98%
EPS 5Y14.35%
EPS Q2Q%19.51%
Revenue 1Y (TTM)9.71%
Revenue growth 3Y9.03%
Revenue growth 5Y8.48%
Sales Q2Q%9.05%

3.2 Future

  • Based on estimates for the next years, UHS will show a small growth in Earnings Per Share. The EPS will grow by 7.50% on average per year.
  • The Revenue is expected to grow by 4.27% on average over the next years.
EPS Next Y9.63%
EPS Next 2Y9.29%
EPS Next 3Y9.15%
EPS Next 5Y7.5%
Revenue Next Year5.98%
Revenue Next 2Y5.38%
Revenue Next 3Y5.31%
Revenue Next 5Y4.27%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
UHS Yearly Revenue VS EstimatesUHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B
UHS Yearly EPS VS EstimatesUHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15 20 25

More info and screens

Find the best growth stocksShow best growing peers

8

4. UHS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 8.85, the valuation of UHS can be described as very reasonable.
  • Based on the Price/Earnings ratio, UHS is valued cheaply inside the industry as 96.04% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.29. UHS is valued rather cheaply when compared to this.
  • UHS is valuated reasonably with a Price/Forward Earnings ratio of 8.08.
  • Based on the Price/Forward Earnings ratio, UHS is valued cheaper than 94.06% of the companies in the same industry.
  • UHS is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.57, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.85
Fwd PE 8.08
UHS Price Earnings VS Forward Price EarningsUHS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of UHS indicates a rather cheap valuation: UHS is cheaper than 89.11% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, UHS is valued a bit cheaper than the industry average as 76.24% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.86
EV/EBITDA 6.37
UHS Per share dataUHS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • UHS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.92
PEG (5Y)0.62
EPS Next 2Y9.29%
EPS Next 3Y9.15%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. UHS Dividend Analysis

5.1 Amount

  • UHS has a yearly dividend return of 0.41%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.49, UHS pays a better dividend. On top of this UHS pays more dividend than 80.20% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, UHS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.41%

5.2 History

  • The dividend of UHS is nicely growing with an annual growth rate of 32.23%!
  • UHS has been paying a dividend for at least 10 years, so it has a reliable track record.
  • UHS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)32.23%
Div Incr Years0
Div Non Decr Years4
UHS Yearly Dividends per shareUHS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • 3.44% of the earnings are spent on dividend by UHS. This is a low number and sustainable payout ratio.
  • The dividend of UHS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP3.44%
EPS Next 2Y9.29%
EPS Next 3Y9.15%
UHS Yearly Income VS Free CF VS DividendUHS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
UHS Dividend Payout.UHS Dividend Payout, showing the Payout Ratio.UHS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

UHS Fundamentals: All Metrics, Ratios and Statistics

UNIVERSAL HEALTH SERVICES-B

NYSE:UHS (3/6/2026, 7:52:17 PM)

After market: 192.65 0 (0%)

192.65

-4.31 (-2.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)04-27
Inst Owners97.33%
Inst Owner Change-1.66%
Ins Owners5.83%
Ins Owner Change2.62%
Market Cap11.77B
Revenue(TTM)17.36B
Net Income(TTM)1.49B
Analysts70.37
Price Target252.08 (30.85%)
Short Float %3.82%
Short Ratio2.57
Dividend
Industry RankSector Rank
Dividend Yield 0.41%
Yearly Dividend0.81
Dividend Growth(5Y)32.23%
DP3.44%
Div Incr Years0
Div Non Decr Years4
Ex-Date03-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.59%
Min EPS beat(2)-1.33%
Max EPS beat(2)16.52%
EPS beat(4)3
Avg EPS beat(4)8.24%
Min EPS beat(4)-1.33%
Max EPS beat(4)16.52%
EPS beat(8)7
Avg EPS beat(8)12.07%
EPS beat(12)11
Avg EPS beat(12)9.91%
EPS beat(16)13
Avg EPS beat(16)6.42%
Revenue beat(2)1
Avg Revenue beat(2)0.55%
Min Revenue beat(2)-1.34%
Max Revenue beat(2)2.44%
Revenue beat(4)2
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-2.29%
Max Revenue beat(4)2.44%
Revenue beat(8)6
Avg Revenue beat(8)0.26%
Revenue beat(12)8
Avg Revenue beat(12)0.15%
Revenue beat(16)12
Avg Revenue beat(16)0.29%
PT rev (1m)-0.95%
PT rev (3m)1.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.31%
EPS NY rev (1m)0%
EPS NY rev (3m)2.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.46%
Valuation
Industry RankSector Rank
PE 8.85
Fwd PE 8.08
P/S 0.68
P/FCF 13.86
P/OCF 6.31
P/B 1.62
P/tB 3.58
EV/EBITDA 6.37
EPS(TTM)21.76
EY11.3%
EPS(NY)23.86
Fwd EY12.38%
FCF(TTM)13.9
FCFY7.22%
OCF(TTM)30.52
OCFY15.84%
SpS284.25
BVpS119.1
TBVpS53.78
PEG (NY)0.92
PEG (5Y)0.62
Graham Number241.48
Profitability
Industry RankSector Rank
ROA 9.59%
ROE 20.46%
ROCE 16.23%
ROIC 12.52%
ROICexc 12.66%
ROICexgc 18.85%
OM 11.48%
PM (TTM) 8.57%
GM N/A
FCFM 4.89%
ROA(3y)7.54%
ROA(5y)7.04%
ROE(3y)16.42%
ROE(5y)15.38%
ROIC(3y)10.23%
ROIC(5y)9.37%
ROICexc(3y)10.34%
ROICexc(5y)9.46%
ROICexgc(3y)15.38%
ROICexgc(5y)14.27%
ROCE(3y)13.26%
ROCE(5y)12.14%
ROICexgc growth 3Y22.6%
ROICexgc growth 5Y1.17%
ROICexc growth 3Y23.35%
ROICexc growth 5Y3.38%
OM growth 3Y15.31%
OM growth 5Y-0.46%
PM growth 3Y19.4%
PM growth 5Y1.04%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 5.6
Debt/EBITDA 1.53
Cap/Depr 164.07%
Cap/Sales 5.85%
Interest Coverage 12.78
Cash Conversion 71.36%
Profit Quality 57.04%
Current Ratio 1.05
Quick Ratio 0.98
Altman-Z 3.08
F-Score8
WACC7.61%
ROIC/WACC1.64
Cap/Depr(3y)152.09%
Cap/Depr(5y)148.58%
Cap/Sales(3y)5.67%
Cap/Sales(5y)5.85%
Profit Quality(3y)76.18%
Profit Quality(5y)54.04%
High Growth Momentum
Growth
EPS 1Y (TTM)30.77%
EPS 3Y29.98%
EPS 5Y14.35%
EPS Q2Q%19.51%
EPS Next Y9.63%
EPS Next 2Y9.29%
EPS Next 3Y9.15%
EPS Next 5Y7.5%
Revenue 1Y (TTM)9.71%
Revenue growth 3Y9.03%
Revenue growth 5Y8.48%
Sales Q2Q%9.05%
Revenue Next Year5.98%
Revenue Next 2Y5.38%
Revenue Next 3Y5.31%
Revenue Next 5Y4.27%
EBIT growth 1Y18.56%
EBIT growth 3Y25.72%
EBIT growth 5Y7.99%
EBIT Next Year34.17%
EBIT Next 3Y13.52%
EBIT Next 5YN/A
FCF growth 1Y-24.4%
FCF growth 3Y47.99%
FCF growth 5Y-12.18%
OCF growth 1Y-9.81%
OCF growth 3Y23.24%
OCF growth 5Y-4.61%

UNIVERSAL HEALTH SERVICES-B / UHS FAQ

What is the fundamental rating for UHS stock?

ChartMill assigns a fundamental rating of 6 / 10 to UHS.


Can you provide the valuation status for UNIVERSAL HEALTH SERVICES-B?

ChartMill assigns a valuation rating of 8 / 10 to UNIVERSAL HEALTH SERVICES-B (UHS). This can be considered as Undervalued.


What is the profitability of UHS stock?

UNIVERSAL HEALTH SERVICES-B (UHS) has a profitability rating of 7 / 10.


What is the financial health of UNIVERSAL HEALTH SERVICES-B (UHS) stock?

The financial health rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 5 / 10.


How sustainable is the dividend of UNIVERSAL HEALTH SERVICES-B (UHS) stock?

The dividend rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 5 / 10 and the dividend payout ratio is 3.44%.